A review of the latest research on Mpro targeting SARS-COV inhibitors-Reference-Cited by-同舟云学术

A review of the latest research on Mpro targeting SARS-COV inhibitors

Published:2021 Issue:7 Volume:12 Page:1026-1036
ISSN:2632-8682
Container-title:RSC Medicinal Chemistry
language:en
Short-container-title:RSC Med. Chem.

Author:

Yang Huihui¹²³⁴,Yang Jinfei⁵⁶⁷⁴¹^ORCID

Affiliation:

1. Medical School Institute of Reproductive Medicine

2. Nantong University

3. Nantong 226019

4. China

5. Institute of Modern Rehabilitation

6. University of Health and Rehabilitation Science

7. Qingdao 266001

Abstract

Since the outbreak of COVID-19, the pandemic caused by SARS-CoV-2 infection is still spreading at an alarming rate and has caused huge loss of life and economic damage worldwide.

Funder

Taishan Scholar Foundation of Shandong Province

Six Talent Peaks Project in Jiangsu Province

Publisher

Royal Society of Chemistry (RSC)

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biochemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2021/MD/D1MD00066G

Reference71 articles.

1. A new coronavirus associated with human respiratory disease in China

2. A pneumonia outbreak associated with a new coronavirus of probable bat origin

3. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

4. Ebola virus disease: 11 323 deaths later, how far have we come?

5. Zika virus: History, emergence, biology, and prospects for control

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breaking the Chain: Protease Inhibitors as Game Changers in Respiratory Viruses Management;International Journal of Molecular Sciences;2024-07-25

2. Design, synthesis and biological evaluation of betulinic acid derivatives as potential inhibitors of 3CL-protease of SARS-CoV-2;Steroids;2024-02

3. Development of a new experimental NMR strategy for covalent cysteine protease inhibitors screening: toward enhanced drug discovery;RSC Advances;2024

4. On the origins of SARS-CoV-2 main protease inhibitors;RSC Medicinal Chemistry;2024

5. Design, synthesis and biological evaluation of peptidomimetic benzothiazolyl ketones as 3CLpro inhibitors against SARS-CoV-2;European Journal of Medicinal Chemistry;2023-09